↓ Skip to main content

Hyperbaric oxygen therapy for multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, January 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
15 tweeters
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Hyperbaric oxygen therapy for multiple sclerosis
Published in
Cochrane database of systematic reviews, January 2004
DOI 10.1002/14651858.cd003057.pub2
Pubmed ID
Authors

Michael H Bennett, Robert Heard

Abstract

Multiple Sclerosis (MS) is a chronic, recurrent and progressive illness with no cure. On the basis of speculative pathophysiology, it has been suggested that Hyperbaric Oxygen Therapy (HBOT) may slow or reverse the progress of the disease.

Twitter Demographics

The data shown below were collected from the profiles of 15 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 9%
United States 1 9%
Romania 1 9%
Unknown 8 73%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 118%
Student > Bachelor 5 45%
Student > Doctoral Student 5 45%
Researcher 4 36%
Student > Master 3 27%
Other 4 36%
Readers by discipline Count As %
Psychology 16 145%
Social Sciences 5 45%
Business, Management and Accounting 3 27%
Engineering 3 27%
Unspecified 2 18%
Other 5 45%

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 January 2015.
All research outputs
#909,381
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#2,639
of 8,923 outputs
Outputs of similar age
#8,253
of 117,280 outputs
Outputs of similar age from Cochrane database of systematic reviews
#16
of 110 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 117,280 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 110 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.